TipHub

327.1

-1.21 -0.37%

As of 27 Jul 2026 · delayed

NSE Listed

Jupiter Life Line Hospitals Ltd. (JLHL)

Volume: 1,47,546Avg Vol 1W: 70,455.2Avg Vol 1M: 39,647.0552W Range:235.61,625
Key Ratios
Checked 2d ago
Market Cap₹10,753 Cr
Current Price₹327.1
Previous Close₹328.31
High / Low (52w)₹1,625 / ₹235.6
Volume1,47,546
Avg Vol (1W)70,455.2
Avg Vol (1M)39,647.05
Stock P/E56.75
Book Value₹47.1
Dividend Yield6%
ROE12.56%
ROA8.15%
Revenue (TTM)₹1,542 Cr
Revenue Growth17.5%
Profit Margin12.94%
Total Debt₹322 Cr
Shares Outstanding33 Cr
Face Value₹10
EPS (TTM)₹5.78
P/B6.96
Debt / Equity0.34
50 DMA₹1,361.11
200 DMA₹1,352.46
Day change-0.37%
Price Chart
327.1 77.27% · 1Y
159532323.4L
2025-07-29
2026-07-27

20-day avg volume: 40K shares

Pros
  • Pays a dividend yield of 6.0%.
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 57.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹289 Cr₹335 Cr₹333 Cr₹337 Cr₹353 Cr₹394 Cr₹365 Cr₹388 Cr
EBITDA₹61 Cr₹71 Cr₹70 Cr₹69 Cr₹70 Cr₹82 Cr₹71 Cr₹75 Cr
Net Profit₹44 Cr₹52 Cr₹52 Cr₹45 Cr₹44 Cr₹57 Cr₹43 Cr₹50 Cr
EPS
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹270 Cr₹1,331 Cr₹274 Cr₹278 Cr₹316 Cr₹291 Cr₹1,542 Cr₹312 Cr
EBITDA₹65 Cr₹271 Cr₹66 Cr₹64 Cr₹73 Cr₹68 Cr₹298 Cr₹69 Cr
Net Profit₹49 Cr₹193 Cr₹44 Cr₹43 Cr₹55 Cr₹44 Cr₹194 Cr₹49 Cr
EPS29.4729.59
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹603 Cr₹789 Cr₹909 Cr₹986 Cr₹1,281 Cr₹1,936 Cr₹2,383 Cr
Total Liabilities₹366 Cr₹542 Cr₹620 Cr₹622 Cr₹113 Cr₹579 Cr₹839 Cr
Equity₹237 Cr₹246 Cr₹288 Cr₹364 Cr₹1,169 Cr₹1,356 Cr₹1,544 Cr
Total Debt
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹89 Cr₹133 Cr₹146 Cr₹196 Cr₹164 Cr₹331 Cr₹332 Cr
Investing₹-43 Cr₹-296 Cr₹-85 Cr₹-94 Cr₹-246 Cr₹-497 Cr₹-442 Cr
Financing₹-32 Cr₹184 Cr₹32 Cr₹-51 Cr₹128 Cr₹297 Cr₹136 Cr
Free Cash Flow₹89 Cr₹133 Cr₹146 Cr₹196 Cr₹164 Cr₹331 Cr₹332 Cr
Shareholding
Promoter 40.91% Institutions 25.88% Public 33.21%
Efficiency & Working Capital
ROCE13.8%
Interest Coverage9
Dividend Payout
Debtor Days18 d
Inventory Days9 d
Payable Days23 d
Cash Conversion Cycle4 d
Working Capital Days28 d
Shareholding Details

As of 2026-06-30

Promoter40.9%
FII9.4%
DII16.5%
Institutions25.9%
Public33.2%
Promoter Pledge0%
No. of Shareholders33,194
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters40.9%40.9%40.9%40.9%40.9%40.9%40.9%40.9%40.9%40.9%40.9%40.9%
FIIs4.6%4%4.2%6.1%8.8%10%10%9.8%9.1%8.5%8.5%9.4%
DIIs12.3%13.6%17.6%17.3%16.9%15.7%15.6%15.8%17%17.4%17%16.5%
Public42.1%41.5%37.3%35.8%33.4%33.3%33.4%33.5%33.1%33.2%33.6%33.2%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders54,78239,34835,10735,79734,08133,91433,95634,19234,36133,62032,98533,194
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Ajay Pratap ThakkerShareholding of Promoter and Promoter Group20.7%1.36 Cr
Western Medical Solutions LlpShareholding of Promoter and Promoter Group8.7%57,03,797
Sbi Healthcare Opportunities FundPublic Shareholding7.8%50,96,817
Ankit Ajay ThakkerShareholding of Promoter and Promoter Group6.7%43,75,789
Jm Financial Products LimitedPublic Shareholding3.4%22,40,000
Goldman Sachs Funds -goldman Sachsindia Equity PPublic Shareholding2.8%18,05,856
Mihir Wire Industries Pvt LtdPublic Shareholding2.2%14,10,000
Neeta Devang GandhiShareholding of Promoter and Promoter Group2.1%13,80,000
Kirtika Ajay ThakkerShareholding of Promoter and Promoter Group2%13,32,750
Sbi Life Insurance Co. LtdPublic Shareholding2%13,17,140
Dr Navin Ramji DavdaPublic Shareholding2%13,10,700
Jm Financial And Investment Consultancy ServicesPublic Shareholding1.9%12,50,000
Ramakant Jagdish TibrewalaPublic Shareholding1.9%12,25,000
Nitin Manilal ThakkerPublic Shareholding1.9%12,20,000
Brijesh Ramakant TibrewalaPublic Shareholding1.8%11,81,772
Mahesh Ramakant TibrewalaPublic Shareholding1.8%11,81,736
Kamini A RaoPublic Shareholding1.6%10,66,975
Snk Investments Private LimitedPublic Shareholding1.4%9,10,000
Sushma Ramakant TibrewalaPublic Shareholding1.2%8,00,750
Mitul Nitin ThakkerPublic Shareholding1.2%7,99,750
Vyshnavi RaoPublic Shareholding1.2%7,68,937
Pooja Sidharth RaoPublic Shareholding1.2%7,64,311
Rajesh Hiralal VoraPublic Shareholding1.1%7,47,998
Abu Dhabi Investment Authority MonsoonPublic Shareholding1%6,83,570
Girish Shamji GalaPublic Shareholding1%6,69,000
Board of Directors
NameDesignationYear
AJAY PRATAP THAKKERChairman & Managing Director2026
Vadapatra Sayee RaghavanNon-Exec & Non-Independent Dir2026
Satish UtekarIndependent Non Exe. Director2026
ANKIT AJAY THAKKERED / Joint MD / CEO / Promoter2026
DARSHAN HIRALAL VORAIndependent Non Exe. Director2026
Urmi PopatIndependent Non Exe. Director2026
JASMIN A PATELIndependent Non Exe. Director2026
Amar ManjrekarIndependent Non Exe. Director2026
Suma UpparattiCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Healthcare services₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10806666
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-31Board Meetings
split2026-07-24Stock Split From Rs.10/- to Rs.2/-
forthcoming2026-07-24Split (Old FV = 10/-; New FV= 2/-)
split2026-07-241:5face value change from 10 to 2
dividend2026-05-22₹1 (10%)Interim
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202614000129161
202613000618
202612600123142
Substantial Acquisitions (SAST)

1 disclosure(s)

Market18/09/2023 · 39,65,000
Company Information
Incorporated2002
ChairmanAJAY PRATAP THAKKER
AuditorAswin P Malde & Co/KKC & Associates LLP
Investor Email[email protected]
🌐 www.jupiterhospital.com

📍 1004 Xth Flr 360 Degree Busi., Park LBS Marg Mulund (West), Mumbai, Maharashtra, 400080

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search